Company Filing History:
28 out of 33 
9 out of 4,945 
1 out of 53 Years Active: 2004-2012
Title: Innovations by Susan E. Hahn in Cancer Treatment
Introduction
Susan E. Hahn is a distinguished inventor based in Toronto, Canada, known for her significant contributions to the field of medicine, particularly in cancer research. With a remarkable portfolio comprising 37 patents, her innovative work focuses on developing therapeutic and diagnostic tools for cancer treatment.
Latest Patents
Among her latest inventions, Susan has developed a method for producing cancerous disease-modifying antibodies. This novel approach utilizes a unique screening paradigm that segregates anti-cancer antibodies by utilizing cancer cell cytotoxicity as an end point. This breakthrough method allows for the production of antibodies that serve both therapeutic and diagnostic purposes. These antibodies can aid in the staging and diagnosis of various cancers and can be employed to treat primary tumors and metastases. Furthermore, they can be conjugated to various agents, including toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties, and hematogenous cells.
Career Highlights
Susan has earned an esteemed career within the pharmaceutical and biotech industries, having worked with renowned companies such as Arius Research, Inc. and Hoffmann-La Roche Inc. Her expertise and dedication to her research have led to numerous advancements in cancer therapies.
Collaborations
Throughout her career, Susan has collaborated with notable professionals in her field, including David S. F. Young and Helen P. Findlay. These collaborations have fostered an environment of innovation and have played a critical role in advancing her research endeavors.
Conclusion
In conclusion, Susan E. Hahn stands as a leading figure in cancer research and innovation. Her 37 patents demonstrate her commitment to improving patient outcomes through the development of cutting-edge therapeutic and diagnostic solutions. As she continues to forge ahead in her career, her work is poised to have a lasting impact on the landscape of cancer treatment.